4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-14-077550
CIK 0001411158operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:04 PM ET
Size
11.2 KB
Accession
0001209191-14-077550
Insider Transaction Report
Form 4
Chanda Sanjay
VP & Interim Head of Drug Deve
Transactions
- Exercise/Conversion
Common Stock
2014-12-19$6.92/sh+7,011$48,516→ 11,006 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-19$6.92/sh−7,011$48,516→ 18,489 totalExercise: $6.92Exp: 2021-03-31→ Common Stock (7,011 underlying) - Exercise/Conversion
Common Stock
2014-12-19$5.59/sh+12,062$67,427→ 23,068 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-19$5.59/sh−12,062$67,427→ 14,938 totalExercise: $5.59Exp: 2022-03-13→ Common Stock (12,062 underlying)
Footnotes (2)
- [F1]1/4 of the shares subject to the option shall vest and become exercisable on the twelve-month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable each month thereafter. The Vesting Commencement Date is January 1, 2011.
- [F2]1/4 of the shares subject to the option shall vest and become exercisable on the twelve-month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable each month thereafter. The Vesting Commencement Date is January 1, 2012.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 8:04 PM ET
- Size
- 11.2 KB